Author

Aman Chauhan

Observed name: MD Aman Chauhan,

Observed institutions: University of Miami, Sylvester Comprehensive Cancer Center

OpenAlex ID: A5019963696

Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting

2023 · Simron Singh, Thomas A Hope, et al. · JNCI Journal of the National Cancer Institute · 12

Investigator-Assessed Disease Progression in a Phase 2 Study of Paltusotine in Patients with Neuroendocrine Tumors and Carcinoid Syndrome

2026 · MD Amr Mohamed,, MD, MBA Michael J. Demeure,, et al. · Endocrine Abstracts · 1

Multicenter Phase 2 Trial of Yttrium-90 Radioembolization with Capecitabine-Temozolomide for Grade 2 Liver-Dominant Metastatic Neuroendocrine Tumors: interim report

2026 · MD Michael C Soulen,, MD Renuka Iyer,, et al. · Endocrine Abstracts

CAREFNDR: Phase 3, Randomized, Placebo-Controlled Study of Paltusotine in Adults With Carcinoid Syndrome Due to Well-Differentiated Neuroendocrine Tumors

2026 · MD Aman Chauhan,, MD Martyn Caplin,, et al. · Endocrine Abstracts

Works count: 4

Citation count: 13

H-index: 1

I10-index: 1